Headshot

Angelika Joos

Executive Director Merck Sharp & Dohme (MSD)

Angelika Joos is a trained pharmacist. She is responsible for International Regulatory & Clinical Policy issues within MSD’s Global Regulatory Affairs and Clinical Safety department. This role includes identifying regulatory policy priorities that align with MSD’s business priorities, leading cross-functional networks to define policy positions, and informing MSD’s regulatory strategy development.

Angelika represents MSD in the IFPMA Regulatory Science Committee and is one of IFPMA’s delegates to the ICH Management Committee. She is also involved in international policy activities though EFPIA as well as the BIO and the PhRMA international committees.

See Angelika Joos at this event

  • Day 4 Friday 6 December

ICH: Driving global harmonization to advance global health

07:30 - 08:15 CET / 17:30 - 18:15 AEDT

Session objectives:

  • Emphasize the importance and benefits of ICH Membership
    Present the IFPMA role in ICH, underlining the involvement of Asian experts in IFPMA Task Forces.
  • Share a Success Story of a National Regulatory Authority (NRA), illustrating the process and the benefits realized.